Key regions: Brazil, India, Australia, United States, United Kingdom
The Antiviral Drugs market in South America has been experiencing significant growth in recent years, driven by various factors such as increasing prevalence of viral infections, rising awareness about antiviral drugs, and growing demand for effective treatment options.
Customer preferences: Customers in South America are increasingly looking for antiviral drugs that are effective, affordable, and have minimal side effects. They also tend to prefer drugs that are easily accessible and available over-the-counter, as many people in the region may not have easy access to healthcare facilities.
Trends in the market: One of the major trends in the Antiviral Drugs market in South America is the increasing demand for drugs to treat HIV/AIDS. This is due to the high prevalence of the disease in the region, particularly in countries such as Brazil and Colombia. Another trend is the growing demand for drugs to treat hepatitis B and C, which are also common in South America. In addition, there is a rising trend towards the development of new antiviral drugs that are more effective and have fewer side effects.
Local special circumstances: South America is a diverse region with varying levels of healthcare infrastructure and access to medical facilities. In some countries, such as Brazil and Argentina, there is a well-developed healthcare system with a strong focus on research and development. However, in other countries, such as Bolivia and Paraguay, access to healthcare is limited, and many people may not have access to the latest antiviral drugs.
Underlying macroeconomic factors: The Antiviral Drugs market in South America is also influenced by various macroeconomic factors, such as government policies, economic growth, and healthcare spending. In recent years, many governments in the region have increased their healthcare spending, which has helped to drive growth in the market. However, economic instability and political uncertainty in some countries, such as Venezuela, can have a negative impact on the market. Overall, the Antiviral Drugs market in South America is expected to continue to grow in the coming years, driven by increasing demand for effective treatment options and the development of new drugs.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
